Autoimmune mediated thrombocytopenia associated with the use of interferon-α in chronic myeloid leukemia

Haematologica

Volumn 81, Issue 6, 1996, Pages 533-536

  Zuffa, Eliana ^a,c   Vianelli, Nicola ^a   Martinelli, Giovanni ^a   Tazzari, Pierluigi ^b   Cavo, Michele ^a   Tura, Sante ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Musculoskeletal Tissue Bank   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chronic myeloid leukemia; Interferon 2A; PAIg; Thrombocytopenia

Indexed keywords

ALPHA2A INTERFERON; CORTICOSTEROID;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CORTICOSTEROID THERAPY; FLOW CYTOMETRY; HUMAN; MALE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BLOOD PLATELETS; HUMANS; INTERFERON ALFA-2A; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; THROMBOCYTOPENIA;

EID: 0030326373     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alpha-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994; 330:820-5.
2. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome positive patients. Ann Intern Med 1991; 114:532-8.
3. Dowding C, Guo A-P, Osterholz J, Siczkowski M, Goldman M, Gordon M. Interferon alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood 1991; 78:499-505.
4. Galvani DW, Cawley JC. Mechanism of action of alpha interferon in chronic granulocytic leukaemia: evidence for preferential inhibition of late progenitors. Br J Haematol 1989; 73:475-9.
5. Muller CA, Walz J, Zinser R, Buhring HJ, Steinke B, Schmidt H. In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN-α treatment. Ann Hematol 1991; 63:259-63.
6. Tazzari PL, Ricci F, Vianelli N, et al. Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. Ann Hematol 1995; 70:267-72.
7. Ganser H, Greher J, Volkers B, Hoelzer D. Effect of recombinant IFN-α and γ on human bone marrow-derived MKC progenitor cells. Blood 1987; 7 0:1173-9.
8. Martinelli G, Zaccaria A, Saglio G, et al. Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I-B35 molecules: relationship between antigen defective cell lines and HLA frequencies in CML patients. Leukemia 1996; 9:1795-6.
9. Silvestri F, Virgolini L, Mazzolini A, et al. Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons. Haematologica 1994; 79:367-70.
10. McLaughlin P, Talpaz M, Quesada JR, Saleem A, Barlogie B, Gutterman JU. Immune thrombocytopenia following α-interferon therapy in patients with cancer. JAMA 1985; 254: 1353-4.
11. Abdi EA, Brien W, Venner PM. Auto-immune thrombocytopenia related to interferon therapy. Scand J Haematol 1986; 36:515-9.
12. Lotzova E, Savary CA, Gutterman JU, Hersh EM. Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-α. Cancer Res 1982; 42:2480-8.